FHIR © HL7.org  |  FHIRsmith 4.0.1  |  Server Home  |  XIG Home  |  XIG Stats  | 

FHIR IG analytics

ValueSets

83,706 resources

Source: Text:

By Version

By Authority

By Realm

 

Start Prev Rows 42200 - 42400 Next

PackageVersionIdentityName/TitleStatusFMMWGDateRealmAuthSource(s)
fhir.bfarm.deR4ValueSet-HealthAppHistoryEntryType.jsonValueSet for HealthAppHistoryEntryTypeactiveushl7
fhir.bfarm.deR4ValueSet-HealthAppIcd.jsonValueSet for HealthAppIcdactiveushl7icd
fhir.bfarm.deR4ValueSet-HealthAppManufacturerType.jsonValueSet for HealthAppManufacturerTypeactiveushl7
fhir.bfarm.deR4ValueSet-HealthAppPlatformType.jsonValueSet for HealthAppPlatformTypeactiveushl7
fhir.bfarm.deR4ValueSet-HealthAppPriceCode.jsonValueSet for HealthAppPriceCodeactiveushl7
fhir.bfarm.deR4ValueSet-HealthAppRegulatoryBasis.jsonValueSet for HealthAppRegulatoryBasisactiveushl7
fhir.bfarm.deR4ValueSet-HealthAppRiskClass.jsonValueSet for HealthAppRiskClassactiveushl7
fhir.bfarm.deR4ValueSet-HealthAppSeverity.jsonValueSet for HealthAppSeverityactiveushl7
hl7.fhir.us.breastcancerR3ValueSet-shr-core-AllUnitsVS.jsonBC AllUnitsVS ValueSetdraft2018-08ushl7ucum iso
fhir.erezept.validatorR4ValueSet-E-Rezept-Allergy-Substance-ACT.jsonE_Rezept_Allergy_Substance_ACTactiveushl7atc
signal.core.r4R4valueset-gender-identity.jsonGender Identityactive2022-03ushl7vsac
us.nlm.vsacR4ValueSet-1.3.6.1.4.1.33895.1.3.0.45.jsonComfort Measuresactive2021-02ushl7sct
us.nlm.vsacR4ValueSet-1.3.6.1.4.1.6997.4.1.2.234.13.18.1.1.11.1.999.1.jsonpain medication action planactive2015-08ushl7sct
us.nlm.vsacR4ValueSet-1.3.6.1.4.1.6997.4.1.2.234.999.3.2.jsonAll prescribable opioids used for pain control including Inactive Medicationsactive2015-08ushl7rx
us.nlm.vsacR4ValueSet-1.3.6.1.4.1.6997.4.1.2.234.999.4.1.jsonmalignant neoplasms and cancer painactive2015-08ushl7icd
us.nlm.vsacR4ValueSet-1.3.6.1.4.1.6997.4.1.2.234.999.4.2.jsonmalignant neoplasms and cancer painactive2015-08ushl7icd
us.nlm.vsacR4ValueSet-1.3.6.1.4.1.6997.4.1.2.234.999.4.7.jsonmalignant neoplasms and cancer painactive2015-08ushl7sct
us.nlm.vsacR4ValueSet-1.3.6.1.4.1.6997.4.1.2.234.999.4.9.jsonmalignancy or cancer related painactive2015-08ushl7vsac
us.nlm.vsacR4ValueSet-1.3.6.1.4.1.6997.4.1.2.265.13.31172.1.1.999.150.jsonCerumen on Otoscopyactive2017-02ushl7sct
us.nlm.vsacR4ValueSet-1.3.6.1.4.1.6997.4.1.2.265.13.31172.1.1.999.151.jsonCerumen on Otoscopyactive2017-02ushl7icd
us.nlm.vsacR4ValueSet-1.3.6.1.4.1.6997.4.1.2.265.13.31172.1.1.999.152.jsonCerumen on Otoscopyactive2017-02ushl7icd
us.nlm.vsacR4ValueSet-1.3.6.1.4.1.6997.4.1.2.265.13.31182.1.12.1.999.172.jsonHearing Lossactive2017-02ushl7sct
us.nlm.vsacR4ValueSet-1.3.6.1.4.1.6997.4.1.2.265.13.31182.1.12.1.999.173.jsonHearing Lossactive2017-02ushl7icd
us.nlm.vsacR4ValueSet-1.3.6.1.4.1.6997.4.1.2.265.13.31182.1.12.1.999.174.jsonHearing Lossactive2017-02ushl7icd
us.nlm.vsacR4ValueSet-1.3.6.1.4.1.6997.4.1.2.265.13.31182.1.13.1.999.175.jsonTinnitusactive2017-03ushl7sct
us.nlm.vsacR4ValueSet-1.3.6.1.4.1.6997.4.1.2.265.13.31182.1.13.1.999.176.jsonTinnitusactive2017-02ushl7icd
us.nlm.vsacR4ValueSet-1.3.6.1.4.1.6997.4.1.2.265.13.31182.1.13.1.999.177.jsonTinnitusactive2017-02ushl7icd
us.nlm.vsacR4ValueSet-1.3.6.1.4.1.6997.4.1.2.265.13.31182.1.14.1.999.178.jsonEar Congestionactive2017-02ushl7sct
us.nlm.vsacR4ValueSet-1.3.6.1.4.1.6997.4.1.2.265.13.31182.1.15.1.999.179.jsonEar Pruritusactive2017-02ushl7sct
us.nlm.vsacR4ValueSet-1.3.6.1.4.1.6997.4.1.2.265.13.31182.1.16.1.999.180.jsonOtalgiaactive2017-03ushl7sct
us.nlm.vsacR4ValueSet-1.3.6.1.4.1.6997.4.1.2.265.13.31182.1.16.1.999.181.jsonOtalgiaactive2017-02ushl7icd
us.nlm.vsacR4ValueSet-1.3.6.1.4.1.6997.4.1.2.265.13.31182.1.16.1.999.182.jsonOtalgiaactive2017-02ushl7icd
us.nlm.vsacR4ValueSet-1.3.6.1.4.1.6997.4.1.2.265.13.31441.1.2.999.96.jsonInitial Encounter with Otolaryngologist or undefined clinicianactive2017-03ushl7sct
us.nlm.vsacR4ValueSet-1.3.6.1.4.1.6997.4.1.2.265.13.31471.1.11.1.999.204.jsonHearing Aidsactive2017-03ushl7icd
us.nlm.vsacR4ValueSet-1.3.6.1.4.1.6997.4.1.2.265.13.31471.1.11.1.999.205.jsonHearing Aidsactive2017-03ushl7icd
us.nlm.vsacR4ValueSet-1.3.6.1.4.1.6997.4.1.2.265.13.31471.1.11.1.999.206.jsonHearing Aidsactive2017-03ushl7icd
us.nlm.vsacR4ValueSet-1.3.6.1.4.1.6997.4.1.2.265.15.31212.1.1.999.81.jsonCerumen Impactionactive2017-03ushl7sct
us.nlm.vsacR4ValueSet-1.3.6.1.4.1.6997.4.1.2.265.15.31212.1.1.999.82.jsonCerumen Impactionactive2017-03ushl7icd
us.nlm.vsacR4ValueSet-1.3.6.1.4.1.6997.4.1.2.265.15.31305.1.11.1.999.190.jsonRadiotherapyactive2017-03ushl7icd
us.nlm.vsacR4ValueSet-1.3.6.1.4.1.6997.4.1.2.265.15.31305.1.11.2.999.191.jsonHead and Neck Anatomic Locationsactive2017-03ushl7sct
us.nlm.vsacR4ValueSet-1.3.6.1.4.1.6997.4.1.2.265.15.31305.1.11.2.999.192.jsonConditions Associated with Head and Neck Radiotherapyactive2017-03ushl7icd
us.nlm.vsacR4ValueSet-1.3.6.1.4.1.6997.4.1.2.265.15.31317.1.1.999.194.jsonEar Canal Stenosisactive2017-03ushl7sct
us.nlm.vsacR4ValueSet-1.3.6.1.4.1.6997.4.1.2.265.15.31317.1.1.999.195.jsonEar Canal Stenosisactive2017-03ushl7icd
us.nlm.vsacR4ValueSet-1.3.6.1.4.1.6997.4.1.2.265.15.31317.1.1.999.196.jsonEar Canal Stenosisactive2017-03ushl7icd
us.nlm.vsacR4ValueSet-1.3.6.1.4.1.6997.4.1.2.265.15.31329.1.1.999.197.jsonExostosesactive2017-03ushl7sct
us.nlm.vsacR4ValueSet-1.3.6.1.4.1.6997.4.1.2.265.15.31329.1.1.999.198.jsonExostosesactive2017-03ushl7icd
us.nlm.vsacR4ValueSet-1.3.6.1.4.1.6997.4.1.2.265.15.31329.1.1.999.199.jsonExostosesactive2017-03ushl7icd
us.nlm.vsacR4ValueSet-1.3.6.1.4.1.6997.4.1.2.265.15.31341.1.1.999.200.jsonNon intact Tympanic Membraneactive2017-03ushl7sct
us.nlm.vsacR4ValueSet-1.3.6.1.4.1.6997.4.1.2.265.15.31341.1.1.999.201.jsonNon Intact Tympanic Membraneactive2017-03ushl7icd
us.nlm.vsacR4ValueSet-1.3.6.1.4.1.6997.4.1.2.265.15.31341.1.1.999.202.jsonNon Intact Tympanic Membraneactive2017-03ushl7icd
us.nlm.vsacR4ValueSet-1.3.6.1.4.1.6997.4.1.2.265.15.31481.1.11.1.999.246.jsonHearing Aidsactive2017-03ushl7sct
us.nlm.vsacR4ValueSet-1.3.6.1.4.1.6997.4.1.2.265.15.31481.1.11.1.999.250.jsonDO NOT USEactive2017-03ushl7sct
us.nlm.vsacR4ValueSet-1.3.6.1.4.1.6997.4.1.2.265.15.31481.1.12.1.999.251.jsonCerumenolyticsactive2017-03ushl7rx
us.nlm.vsacR4ValueSet-1.3.6.1.4.1.6997.4.1.2.265.15.31481.1.12.1.999.252.jsonIrrigationactive2017-03ushl7sct
us.nlm.vsacR4ValueSet-1.3.6.1.4.1.6997.4.1.2.265.15.31481.1.12.1.999.253.jsonIrrigationactive2017-03ushl7icd
us.nlm.vsacR4ValueSet-1.3.6.1.4.1.6997.4.1.2.265.15.31593.1.12.1.999.288.jsonOtoscopy performed on examactive2017-03ushl7sct
us.nlm.vsacR4ValueSet-1.3.6.1.4.1.6997.4.1.2.265.15.31663.1.1.999.291.jsonOtolaryngologist as a Clinician or Serviceactive2017-03ushl7sct
us.nlm.vsacR4ValueSet-1.3.6.1.4.1.6997.4.1.2.265.8.31102.1.1.999.123.jsonCerumen Impactionactive2017-02ushl7icd
us.nlm.vsacR4ValueSet-1.3.6.1.4.1.6997.4.1.2.265.9.31104.1.1.999.275.jsonDermatologic Diseases of the Earactive2017-03ushl7sct
us.nlm.vsacR4ValueSet-1.3.6.1.4.1.6997.4.1.2.265.9.31108.1.1.999.20.jsonKeratoses Obturansactive2017-02ushl7sct
us.nlm.vsacR4ValueSet-1.3.6.1.4.1.6997.4.1.2.265.9.31112.1.11.1.999.221.jsonTympanoplastyactive2017-03ushl7sct
us.nlm.vsacR4ValueSet-1.3.6.1.4.1.6997.4.1.2.265.9.31112.1.11.1.999.222.jsonTympanoplastyactive2017-03ushl7icd
us.nlm.vsacR4ValueSet-1.3.6.1.4.1.6997.4.1.2.265.9.31112.1.12.1.999.223.jsonMyringoplastyactive2017-03ushl7sct
us.nlm.vsacR4ValueSet-1.3.6.1.4.1.6997.4.1.2.265.9.31112.1.12.1.999.224.jsonMyringoplastyactive2017-03ushl7icd
us.nlm.vsacR4ValueSet-1.3.6.1.4.1.6997.4.1.2.265.9.31112.1.13.1.999.225.jsonMastoidectomyactive2017-03ushl7sct
us.nlm.vsacR4ValueSet-1.3.6.1.4.1.6997.4.1.2.265.9.31112.1.13.1.999.229.jsonMastoidectomyactive2017-03ushl7icd
us.nlm.vsacR4ValueSet-1.3.6.1.4.1.6997.4.1.2.265.9.31112.1.14.1.999.227.jsonEar Surgery, Otheractive2017-03ushl7sct
us.nlm.vsacR4ValueSet-1.3.6.1.4.1.6997.4.1.2.265.9.31112.1.14.1.999.228.jsonEar Surgery, Otheractive2018-01ushl7icd
us.nlm.vsacR4ValueSet-1.3.6.1.4.1.6997.4.1.2.268.12.31833.1.1.999.334.jsonSleep Apneaactive2018-05ushl7icd
us.nlm.vsacR4ValueSet-1.3.6.1.4.1.6997.4.1.2.268.12.31833.1.1.999.336.jsonSleep Apneaactive2018-05ushl7sct
us.nlm.vsacR4ValueSet-1.3.6.1.4.1.6997.4.1.2.268.13.34853.1.1.999.237.jsonAllergic Rhinitisactive2017-03ushl7sct
us.nlm.vsacR4ValueSet-1.3.6.1.4.1.6997.4.1.2.268.13.34853.1.1.999.238.jsonAllergic Rhinitisactive2017-03ushl7icd
us.nlm.vsacR4ValueSet-1.3.6.1.4.1.6997.4.1.2.268.13.34853.1.1.999.239.jsonAllergic Rhinitisactive2017-03ushl7icd
us.nlm.vsacR4ValueSet-1.3.6.1.4.1.6997.4.1.2.268.13.34951.1.11.1.999.263.jsonUncontrolled or severe asthmaactive2017-03ushl7sct
us.nlm.vsacR4ValueSet-1.3.6.1.4.1.6997.4.1.2.268.13.34951.1.11.1.999.264.jsonUncontrolled or severe asthmaactive2017-03ushl7icd
us.nlm.vsacR4ValueSet-1.3.6.1.4.1.6997.4.1.2.268.13.34951.1.11.1.999.265.jsonUncontrolled or severe asthmaactive2017-03ushl7icd
us.nlm.vsacR4ValueSet-1.3.6.1.4.1.6997.4.1.2.268.13.35031.1.11.1.999.300.jsonRhinosinusitisactive2017-03ushl7icd
us.nlm.vsacR4ValueSet-1.3.6.1.4.1.6997.4.1.2.268.13.35031.1.11.1.999.301.jsonRhinosinusitisactive2017-03ushl7icd
us.nlm.vsacR4ValueSet-1.3.6.1.4.1.6997.4.1.2.268.13.35031.1.11.1.999.302.jsonRhinosinusitisactive2017-03ushl7sct
us.nlm.vsacR4ValueSet-1.3.6.1.4.1.6997.4.1.2.268.13.35031.1.12.1.999.303.jsonNasal Polyposisactive2017-03ushl7icd
us.nlm.vsacR4ValueSet-1.3.6.1.4.1.6997.4.1.2.268.13.35031.1.12.1.999.304.jsonNasal Polyposisactive2017-03ushl7icd
us.nlm.vsacR4ValueSet-1.3.6.1.4.1.6997.4.1.2.268.13.35031.1.12.1.999.305.jsonNasal Polyposisactive2017-03ushl7sct
us.nlm.vsacR4ValueSet-1.3.6.1.4.1.6997.4.1.2.268.13.35031.1.13.1.999.306.jsonSuspected Nasal Neoplasmactive2017-03ushl7icd
us.nlm.vsacR4ValueSet-1.3.6.1.4.1.6997.4.1.2.268.13.35031.1.13.1.999.307.jsonSuspected Nasal Neoplasmactive2017-03ushl7icd
us.nlm.vsacR4ValueSet-1.3.6.1.4.1.6997.4.1.2.268.13.35031.1.13.1.999.308.jsonSuspected Nasal Neoplasmactive2017-03ushl7sct
us.nlm.vsacR4ValueSet-1.3.6.1.4.1.6997.4.1.2.268.13.35031.1.14.1.999.309.jsonOther sinus conditions potentially requiring imagingactive2017-08ushl7icd
us.nlm.vsacR4ValueSet-1.3.6.1.4.1.6997.4.1.2.268.13.35031.1.14.1.999.310.jsonOther sinus conditions potentially requiring imagingactive2017-08ushl7icd
us.nlm.vsacR4ValueSet-1.3.6.1.4.1.6997.4.1.2.268.13.35211.1.11.1.999.319.jsonIntranasal Antihistaminesactive2017-06ushl7rx
us.nlm.vsacR4ValueSet-1.3.6.1.4.1.6997.4.1.2.268.13.35211.1.12.1.999.320.jsonMast Cell Stabilizersactive2017-06ushl7rx
us.nlm.vsacR4ValueSet-1.3.6.1.4.1.6997.4.1.2.268.13.35211.1.13.1.999.321.jsonOphthalmic Antihistaminesactive2017-06ushl7rx
us.nlm.vsacR4ValueSet-1.3.6.1.4.1.6997.4.1.2.268.13.35282.1.11.1.999.215.jsonSneezing as a findingactive2017-03ushl7sct
us.nlm.vsacR4ValueSet-1.3.6.1.4.1.6997.4.1.2.268.13.35282.1.11.1.999.216.jsonSneezing as a Clinical Conditionactive2017-03ushl7icd
us.nlm.vsacR4ValueSet-1.3.6.1.4.1.6997.4.1.2.268.13.35282.1.12.1.999.217.jsonPruritus Unspecified or Other Locationactive2017-03ushl7sct
us.nlm.vsacR4ValueSet-1.3.6.1.4.1.6997.4.1.2.268.13.35282.1.12.1.999.218.jsonPruritus Unspecified or Other Locationactive2017-03ushl7icd
us.nlm.vsacR4ValueSet-1.3.6.1.4.1.6997.4.1.2.268.15.34907.1.11.1.999.272.jsonSpecific IgE Testing for Allergiesactive2017-03ushl7loinc
us.nlm.vsacR4ValueSet-1.3.6.1.4.1.6997.4.1.2.268.15.34907.1.12.1.999.273.jsonImmunoglobulin G Testingactive2017-03ushl7loinc
us.nlm.vsacR4ValueSet-1.3.6.1.4.1.6997.4.1.2.268.15.34907.1.13.1.999.274.jsonTotal IgE Testingactive2017-03ushl7loinc
us.nlm.vsacR4ValueSet-1.3.6.1.4.1.6997.4.1.2.268.15.34920.1.1.999.290.jsonClinicians who perform allergy testingactive2017-03ushl7sct
us.nlm.vsacR4ValueSet-1.3.6.1.4.1.6997.4.1.2.268.15.35043.1.1.999.279.jsonRadiography of face, head or neckactive2017-03ushl7sct
us.nlm.vsacR4ValueSet-1.3.6.1.4.1.6997.4.1.2.268.15.35221.1.11.1.999.315.jsonIntranasal Corticosteroidsactive2017-03ushl7rx
us.nlm.vsacR4ValueSet-1.3.6.1.4.1.6997.4.1.2.268.15.35221.1.13.1.999.316.jsonEustachian Tube Dysfunctionactive2017-03ushl7icd
us.nlm.vsacR4ValueSet-1.3.6.1.4.1.6997.4.1.2.268.15.35221.1.13.1.999.317.jsonEustachian Tube Dysfunctionactive2017-03ushl7icd
us.nlm.vsacR4ValueSet-1.3.6.1.4.1.6997.4.1.2.268.15.35221.1.13.1.999.318.jsonEustachian Tube Dysfunctionactive2017-03ushl7sct
us.nlm.vsacR4ValueSet-1.3.6.1.4.1.6997.4.1.2.268.15.35292.1.1.999.287.jsonOral Second Generation and Less Sedating Antihistaminesactive2017-05ushl7rx
us.nlm.vsacR4ValueSet-1.3.6.1.4.1.6997.4.1.2.268.15.35464.1.1.999.266.jsonLeukotriene antagonistactive2017-03ushl7rx
us.nlm.vsacR4ValueSet-1.3.6.1.4.1.6997.4.1.2.268.15.35607.1.11.1.999.267.jsonImmunotherapy that is not Identified as Subcutaneousactive2017-03ushl7sct
us.nlm.vsacR4ValueSet-1.3.6.1.4.1.6997.4.1.2.268.15.35607.1.14.1.999.268.jsonImmunotherapyactive2017-03ushl7sct
us.nlm.vsacR4ValueSet-1.3.6.1.4.1.6997.4.1.2.271.12.37641.1.1.999.653.jsonFidaxomicinactive2019-04ushl7rx
us.nlm.vsacR4ValueSet-1.3.6.1.4.1.6997.4.1.2.271.13.37752.1.1.999.655.jsonClostridium difficile infectionactive2019-04ushl7icd
us.nlm.vsacR4ValueSet-1.3.6.1.4.1.6997.4.1.2.271.13.37752.1.1.999.656.jsonClostridium difficile infectionactive2019-04ushl7icd
us.nlm.vsacR4ValueSet-1.3.6.1.4.1.6997.4.1.2.271.13.37752.1.1.999.657.jsonClostridium difficile infectionactive2019-04ushl7sct
us.nlm.vsacR4ValueSet-1.3.6.1.4.1.6997.4.1.2.271.13.38167.1.1.999.594.jsonComplete Blood Count (with Diff)active2019-04ushl7loinc
us.nlm.vsacR4ValueSet-1.3.6.1.4.1.6997.4.1.2.271.13.38256.1.1.999.662.jsonMetronidazole Systemicactive2019-04ushl7rx
us.nlm.vsacR4ValueSet-1.3.6.1.4.1.6997.4.1.2.271.13.38266.1.1.999.663.jsonVancomycin non injectableactive2019-04ushl7rx
us.nlm.vsacR4ValueSet-1.3.6.1.4.1.6997.4.1.2.271.13.38343.1.1.999.665.jsonCreatinineactive2019-04ushl7loinc
us.nlm.vsacR4ValueSet-1.3.6.1.4.1.6997.4.1.2.271.13.38398.1.11.1.999.722.jsonIleus due to infectionactive2019-04ushl7icd
us.nlm.vsacR4ValueSet-1.3.6.1.4.1.6997.4.1.2.271.13.38398.1.11.1.999.723.jsonIleus due to infectionactive2019-04ushl7icd
us.nlm.vsacR4ValueSet-1.3.6.1.4.1.6997.4.1.2.271.13.38398.1.11.1.999.724.jsonIleus due to infectionactive2019-04ushl7sct
us.nlm.vsacR4ValueSet-1.3.6.1.4.1.6997.4.1.2.271.13.38398.1.12.1.999.725.jsonVomiting potentially due to CDIactive2019-04ushl7icd
us.nlm.vsacR4ValueSet-1.3.6.1.4.1.6997.4.1.2.271.13.38398.1.12.1.999.726.jsonVomiting potentially due to CDIactive2019-04ushl7icd
us.nlm.vsacR4ValueSet-1.3.6.1.4.1.6997.4.1.2.271.13.38398.1.12.1.999.727.jsonVomiting potentially due to CDIactive2019-04ushl7sct
us.nlm.vsacR4ValueSet-1.3.6.1.4.1.6997.4.1.2.271.13.38398.1.13.1.999.728.jsonToxic Megacolon in adultsactive2019-04ushl7icd
us.nlm.vsacR4ValueSet-1.3.6.1.4.1.6997.4.1.2.271.13.38398.1.13.1.999.729.jsonToxic Megacolon in adultsactive2019-04ushl7icd
us.nlm.vsacR4ValueSet-1.3.6.1.4.1.6997.4.1.2.271.13.38398.1.13.1.999.730.jsonToxic Megacolon in adultsactive2019-04ushl7sct
us.nlm.vsacR4ValueSet-1.3.6.1.4.1.6997.4.1.2.271.13.38398.1.14.1.999.731.jsonAbdominal Distensionactive2019-04ushl7icd
us.nlm.vsacR4ValueSet-1.3.6.1.4.1.6997.4.1.2.271.13.38398.1.14.1.999.732.jsonAbdominal Distensionactive2019-04ushl7sct
us.nlm.vsacR4ValueSet-1.3.6.1.4.1.6997.4.1.2.271.13.38493.1.1.999.688.jsonSeptic Shock due to C. Diffactive2019-04ushl7icd
us.nlm.vsacR4ValueSet-1.3.6.1.4.1.6997.4.1.2.271.13.38493.1.1.999.689.jsonSeptic Shock due to C. Diffactive2019-04ushl7icd
us.nlm.vsacR4ValueSet-1.3.6.1.4.1.6997.4.1.2.271.13.38493.1.1.999.690.jsonSeptic Shock due to C. Diffactive2019-04ushl7sct
us.nlm.vsacR4ValueSet-1.3.6.1.4.1.6997.4.1.2.271.15.37872.1.1.999.658.jsonAntiperistaltic agents to avoid in C. diffactive2019-04ushl7rx
us.nlm.vsacR4ValueSet-1.3.6.1.4.1.6997.4.1.2.271.15.37872.1.1.999.734.jsonSystemic Antimicrobial Medications not used for CDIactive2019-05ushl7rx
us.nlm.vsacR4ValueSet-1.3.6.1.4.1.6997.4.1.2.271.15.37937.1.11.1.999.659.jsonRecurrent Clostridium difficile infectionactive2019-04ushl7icd
us.nlm.vsacR4ValueSet-1.3.6.1.4.1.6997.4.1.2.271.15.37937.1.13.2.999.660.jsonHistory of CDIactive2019-04ushl7sct
us.nlm.vsacR4ValueSet-1.3.6.1.4.1.6997.4.1.2.271.15.38112.1.1.999.661.jsonConsult Infectious Diseaseactive2019-04ushl7sct
us.nlm.vsacR4ValueSet-1.3.6.1.4.1.6997.4.1.2.271.15.38827.1.1.999.691.jsonAbdominal Xrays for CDIactive2019-04ushl7sct
us.nlm.vsacR4ValueSet-1.3.6.1.4.1.6997.4.1.2.271.15.38839.1.1.999.692.jsonCT of abdomen with contrast for fulminant CDIactive2019-04ushl7sct
us.nlm.vsacR4ValueSet-1.3.6.1.4.1.6997.4.1.2.271.15.38904.1.1.999.693.jsonSurgical consult for CDIactive2019-04ushl7sct
us.nlm.vsacR4ValueSet-1.3.6.1.4.1.6997.4.1.2.271.15.39406.1.1.999.694.jsonFecal microbiota transplantationactive2019-04ushl7sct
us.nlm.vsacR4ValueSet-1.3.6.1.4.1.6997.4.1.2.271.4.37623.1.1.999.645.jsonHospitalistactive2019-04ushl7sct
us.nlm.vsacR4ValueSet-1.3.6.1.4.1.6997.4.1.2.271.8.37627.1.1.999.697.jsonPositive result indicatoractive2019-04ushl7sct
us.nlm.vsacR4ValueSet-1.3.6.1.4.1.6997.4.1.2.271.8.37627.1.1.999.698.jsonClostridium Difficile Testactive2019-04ushl7loinc
us.nlm.vsacR4ValueSet-1.3.6.1.4.1.6997.4.1.2.271.8.37631.1.11.1.999.646.jsonBody Temperatureactive2019-04ushl7sct
us.nlm.vsacR4ValueSet-1.3.6.1.4.1.6997.4.1.2.271.8.37631.1.11.1.999.647.jsonBody Temperatureactive2019-04ushl7loinc
us.nlm.vsacR4ValueSet-1.3.6.1.4.1.6997.4.1.2.271.8.37631.1.12.1.999.648.jsonDiarrhea Potentially due to CDIactive2019-04ushl7sct
us.nlm.vsacR4ValueSet-1.3.6.1.4.1.6997.4.1.2.271.8.37631.1.12.1.999.649.jsonDiarrhea Potentially due to CDIactive2019-04ushl7icd
us.nlm.vsacR4ValueSet-1.3.6.1.4.1.6997.4.1.2.271.8.37631.1.12.1.999.650.jsonDiarrhea Potentially due to CDIactive2019-04ushl7icd
us.nlm.vsacR4ValueSet-1.3.6.1.4.1.6997.4.1.2.271.8.37631.1.13.1.999.651.jsonLeukocyte countactive2019-04ushl7loinc
us.nlm.vsacR4ValueSet-1.3.6.1.4.1.6997.4.1.2.271.9.37637.1.1.999.652.jsonInpatient Settingactive2019-04ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1010.4.jsonMedication Clinical Drugactive2024-06ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1010.5.jsonMedication Clinical Brand specific Drugactive2024-06ushl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1010.6.jsonCVX Vaccines Administered Vaccine Setactive2025-04ushl7cvx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1021.102.jsonUnknown or did not answeractive2021-10ushl7tho
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1021.103.jsonOther or unknown or refused to answeractive2021-11ushl7tho
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1021.12.jsonLow Molecular Weight Heparin for VTE prophylaxis ingredient specificactive2025-04ushl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1021.14.jsonPublished test VSactive2023-06ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1021.24.jsonBirth Sexactive2024-03ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1021.46.jsonDevice Magnetic resonance (MR) Safetyactive2024-06ushl7ncit
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1021.47.jsonDevice Latex Safetyactive2024-06ushl7ncit
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1021.48.jsonImplantable Device Statusactive2024-06ushl7ncit
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1021.56.jsonMedical Reason Not Done SCTactive2019-12ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1029.119.jsonPhototherapyactive2021-06ushl7cms
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1029.120.jsonPhototherapyactive2021-06ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1029.121.jsonPhototherapyactive2022-03ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1029.122.jsonNeonatal Jaundiceactive2023-06ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1029.123.jsonNeonatal Jaundiceactive2025-05ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1029.124.jsonNeonatal Jaundiceactive2021-06ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1029.125.jsonMaternal Drug Useactive2021-06ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1029.126.jsonMaternal Drug Useactive2025-05ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1029.127.jsonMaternal Drug Useactive2021-06ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1029.128.jsonFetal Conditionsactive2025-05ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1029.129.jsonFetal Conditionsactive2024-06ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1029.130.jsonFetal Conditionsactive2021-06ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1029.131.jsonCongenital Malformationsactive2025-05ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1029.132.jsonCongenital Malformationsactive2025-05ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1029.133.jsonCongenital Malformationsactive2021-06ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1029.134.jsonSocial Indicationsactive2024-05ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1029.135.jsonSocial Indicationsactive2025-05ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1029.136.jsonSocial Indicationsactive2021-06ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1029.137.jsonNeonatal Severe Birth Traumaactive2021-06ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1029.138.jsonNeonatal Severe Birth Traumaactive2025-05ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1029.139.jsonNeonatal Severe Birth Traumaactive2021-06ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1029.140.jsonNeonatal Severe Hypoxia or Asphyxiaactive2021-06ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1029.141.jsonNeonatal Severe Hypoxia or Asphyxiaactive2025-05ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1029.142.jsonNeonatal Severe Hypoxia or Asphyxiaactive2021-06ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1029.143.jsonNeonatal Severe Shock and Resuscitationactive2021-06ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1029.144.jsonNeonatal Severe Shock and Resuscitationactive2025-05ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1029.145.jsonNeonatal Severe Shock and Resuscitationactive2021-06ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1029.146.jsonNeonatal Severe Respiratory Complicationsactive2021-06ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1029.147.jsonNeonatal Severe Respiratory Complicationsactive2021-06ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1029.148.jsonNeonatal Severe Respiratory Complicationsactive2021-06ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1029.149.jsonNeonatal Severe Infectionactive2021-06ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1029.150.jsonNeonatal Severe Infectionactive2023-06ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1029.151.jsonNeonatal Severe Infectionactive2021-06ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1029.152.jsonNeonatal Severe Neurological Complicationsactive2021-06ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1029.153.jsonNeonatal Severe Neurological Complicationsactive2024-06ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1029.154.jsonNeonatal Severe Neurological Complicationsactive2021-06ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1029.155.jsonNeonatal Severe Shock and Resuscitation Proceduresactive2021-06ushl7cms
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1029.156.jsonNeonatal Severe Shock and Resuscitation Proceduresactive2025-05ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1029.157.jsonNeonatal Severe Shock and Resuscitation Proceduresactive2022-03ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1029.158.jsonNeonatal Severe Respiratory Proceduresactive2021-06ushl7cms